Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



3-D Printing News Investors Need to Know

3-D printing investors have had some pretty exciting headlines to follow in recent years as a lot of interest builds up behind the potentially disruptive industry. In this video, Motley Fool industrials analyst Blake Bos gives investors some of the most unusual ways that 3-D printing innovators are making science fiction a reality. He tells us that while these are certainly ideas for a long time frame, they may not be as far away as you think.

3D Systems is at the leading edge of a disruptive technological revolution, with the broadest portfolio of 3-D printers in the industry. However, despite years of earnings growth, 3D Systems' share price has risen even faster, and today the company sports a dizzying valuation. To help investors decide whether the future of additive manufacturing is bright enough to justify the lofty price tag on the company's shares, The Motley Fool has compiled a premium research report on whether 3D Systems is a buy right now. In our report, we take a close look at 3D Systems' opportunities, risks, and critical factors for growth. You'll also find reasons to buy or sell, and receive a full year of analyst updates with the report. To start reading, simply click here now for instant access.

Read/Post Comments (3) | Recommend This Article (5)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On February 05, 2013, at 5:11 PM, rongreen1 wrote:

    I am invested in ONVO, DDD and SSYS. The comments about ONVO are not well-informed. 1st, Organovo is mispronounced. 2nd, regulatory approval will not be needed for the tissues ONVO will supply to pharmaceuticals for research.

    Other statements about share dilution and sharing of research are unsubstantiated. They are merely speculation. Besides, every growing company issues more shares. What's the point?

  • Report this Comment On February 06, 2013, at 7:45 AM, 1297US12 wrote:

    Sounds like Motley Fool is trying to do a backstroke. Must have made their money on the big sell off.

  • Report this Comment On February 06, 2013, at 11:25 AM, TMFBos wrote:

    Sorry about the pronunciation Ron; as far as regulatory approval goes I was referring to the stem cell methods described in the video above. You can check it out over at Rapid Ready if you'd like. They do a awesome job covering additive manufacturing.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2236950, ~/Articles/ArticleHandler.aspx, 9/29/2016 8:17:10 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,143.45 -195.79 -1.07%
S&P 500 2,151.13 -20.24 -0.93%
NASD 5,269.15 -49.39 -0.93%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/29/2016 4:01 PM
DDD $17.66 Down -0.07 -0.39%
3D Systems CAPS Rating: ****
ONVO $3.77 Down -0.09 -2.33%
Organovo Holdings CAPS Rating: ***
SSYS $23.95 Up +0.10 +0.42%
Stratasys CAPS Rating: ****